U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546253) titled 'Post-Market Real-World Evidence Registry for the NeuroOne OneRF(R) Ablation System for Epilepsy' on April 06.
Brief Summary: This is a multi-site registry study that aims to collect real-world clinical outcomes and device performance of the OneRF Ablation System. The study focuses on patients with refractory epilepsy who undergo, or are being considered for, sEEG-guided RF ablation using the OneRF Ablation System, as part of routine seizure diagnosis and treatment.
Study Start Date: July, 2026
Study Type: OBSERVATIONAL
Condition:
Drug Resistant Epilepsy
Refractory Epilepsy
Intervention:
OTHER: Participants are not assigned an...